MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 150 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $73,000 | -92.0% | 59,053 | -80.3% | 0.00% | -85.7% |
| Q1 2017 | $918,000 | -26.6% | 299,100 | -2.4% | 0.01% | -36.4% |
| Q4 2016 | $1,251,000 | -36.3% | 306,600 | -0.8% | 0.01% | -35.3% |
| Q3 2016 | $1,963,000 | +27.0% | 309,100 | +7.8% | 0.02% | +21.4% |
| Q2 2016 | $1,546,000 | -39.3% | 286,850 | -5.7% | 0.01% | -41.7% |
| Q1 2016 | $2,547,000 | +5.0% | 304,350 | -0.9% | 0.02% | +4.3% |
| Q4 2015 | $2,426,000 | -8.3% | 307,100 | -1.3% | 0.02% | 0.0% |
| Q3 2015 | $2,647,000 | -40.8% | 311,100 | -14.0% | 0.02% | +228.6% |
| Q2 2015 | $4,474,000 | +9.0% | 361,850 | +4.7% | 0.01% | +16.7% |
| Q1 2015 | $4,104,000 | -5.6% | 345,500 | -10.2% | 0.01% | -14.3% |
| Q4 2014 | $4,347,000 | +16.9% | 384,750 | -9.2% | 0.01% | +16.7% |
| Q3 2014 | $3,720,000 | +20.9% | 423,700 | +0.3% | 0.01% | +20.0% |
| Q2 2014 | $3,078,000 | +60.9% | 422,300 | +11.3% | 0.01% | +66.7% |
| Q1 2014 | $1,913,000 | +28.8% | 379,575 | +36.5% | 0.00% | +50.0% |
| Q4 2013 | $1,485,000 | – | 278,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|